Biotech startup that develops gene therapeutics for muscle wasting diseases. This includes cancer cachexia, muscular dystrophy, sarcopenia, COPD, chronic kidney disease, peripheral nerve damage and more. At AAVogen, we make you stronger! We are seeking corporate partners and independent investors to help us grow. A variety of deal structures are being sought as we are flexible and poised to move rapidly. Please contact Dr. Rodgers for more information.